| Constine, Louis S |
NCT03681535: Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma |
|
|
| Active, not recruiting | N/A | 241 | Europe, Japan, US, RoW | Radiation Therapy | Duke University | Diffuse Large B Cell Lymphoma | 08/25 | 08/28 | | |
| Smudzin, Therese |
DRO2301, NCT06262321: Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax |
|
|
| Recruiting | 2 | 48 | US | Prophylactic Palliative Radiotherapy | University of Rochester | Stage 4 NSCLC, Radiotherapy | 02/29 | 02/29 | | |
NCT05530655: A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer |
|
|
| Recruiting | 1 | 30 | US | Lisinopril Tablets | University of Rochester, Medical College of Wisconsin | Prostate Cancer, Radiation Toxicity, Urinary Complication | 01/26 | 01/26 | | |
NCT04645810: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence |
|
|
| Recruiting | N/A | 12 | US | High-Dose-Rate Brachytherapy | University of Rochester | Prostate Cancer, HDR | 05/26 | 05/27 | | |
NCT04805528: Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck |
|
|
| Recruiting | N/A | 75 | US | Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS) | University of Rochester | Head and Neck Cancer | 05/25 | 05/25 | | |
NCT03681535: Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma |
|
|
| Active, not recruiting | N/A | 241 | Europe, Japan, US, RoW | Radiation Therapy | Duke University | Diffuse Large B Cell Lymphoma | 08/25 | 08/28 | | |
| Ellis, Jessica |
KEYNOTE B84, NCT04815720: Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
|
|
| Completed | 1/2 | 49 | US | pepinemab + pembrolizumab, KEYTRUDA® | Vaccinex Inc., Merck Sharp & Dohme LLC | Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) | 07/24 | 07/24 | | |
|
| Recruiting | 1 | 150 | Europe, US, RoW | OKI-219, Fulvestrant, Trastuzumab | OnKure, Inc. | Advanced Cancer, Breast Cancer | 06/26 | 08/27 | | |
NCT04543201: Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed with High Grade Glioma |
|
|
| Recruiting | N/A | 50 | US | Early START visit using checklist over telephone or zoom | University of Rochester | Glioma | 07/26 | 07/26 | | |
